Ranitidine Tablets USP — Class III drug recall D-0166-2020
Ongoing recall by AuroMedics Pharma LLC, reported 2019-11-06, distributed nationwide. CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
| Recall number | D-0166-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | AuroMedics Pharma LLC, East Windsor, NJ, United States |
| Recall initiated | 2019-09-23 |
| Classified | 2019-10-29 |
| Reported by FDA | 2019-11-06 |
| Distributed | Nationwide (US) |
| Quantity | 69,696 bottles |
| Reason classes | cgmp |
| NDC | 55910-0092-79 |
| Lot numbers | NBSB19001DA3 |
| Expiration dates | 2021-02 |
Product
Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
Reason for recall
CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0166-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.